全文获取类型
收费全文 | 1384篇 |
免费 | 115篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 93篇 |
妇产科学 | 40篇 |
基础医学 | 129篇 |
口腔科学 | 18篇 |
临床医学 | 210篇 |
内科学 | 431篇 |
皮肤病学 | 36篇 |
神经病学 | 73篇 |
特种医学 | 44篇 |
外科学 | 153篇 |
综合类 | 52篇 |
预防医学 | 70篇 |
眼科学 | 16篇 |
药学 | 134篇 |
中国医学 | 2篇 |
肿瘤学 | 90篇 |
出版年
2022年 | 18篇 |
2021年 | 21篇 |
2020年 | 17篇 |
2019年 | 31篇 |
2018年 | 23篇 |
2017年 | 26篇 |
2016年 | 25篇 |
2015年 | 51篇 |
2014年 | 45篇 |
2013年 | 68篇 |
2012年 | 75篇 |
2011年 | 101篇 |
2010年 | 73篇 |
2009年 | 63篇 |
2008年 | 56篇 |
2007年 | 111篇 |
2006年 | 70篇 |
2005年 | 55篇 |
2004年 | 44篇 |
2003年 | 43篇 |
2002年 | 40篇 |
2001年 | 34篇 |
2000年 | 35篇 |
1999年 | 26篇 |
1998年 | 29篇 |
1997年 | 15篇 |
1996年 | 19篇 |
1995年 | 25篇 |
1994年 | 33篇 |
1993年 | 16篇 |
1992年 | 36篇 |
1991年 | 24篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 8篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1982年 | 7篇 |
1981年 | 9篇 |
1979年 | 14篇 |
1978年 | 14篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1973年 | 11篇 |
1972年 | 6篇 |
1971年 | 8篇 |
1968年 | 8篇 |
1967年 | 8篇 |
1966年 | 10篇 |
排序方式: 共有1596条查询结果,搜索用时 31 毫秒
51.
52.
53.
54.
Po-Hong Liu MD Yun-Hsuan Lee MD Cheng-Yuan Hsia MD Chia-Yang Hsu MD Yi-Hsiang Huang MD PhD Yi-You Chiou MD Han-Chieh Lin MD Teh-Ia Huo MD 《Annals of surgical oncology》2014,21(6):1825-1833
Background
The long-term survival in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) who received surgical resection (SR) or transarterial chemoembolization (TACE) remains unclear. We compared the efficacy of SR and TACE by using a propensity score analysis.Methods
A total of 247 and 181 HCC patients with PVTT undergoing SR and TACE, respectively, were evaluated. One hundred eight pairs of matched patients were selected from each treatment arm by using a propensity score analysis.Results
Of all patients, the estimated 1-, 3-, and 5-year survival rates of patients receiving SR and TACE were 85 versus 60 %, 68 versus 42 %, and 61 versus 33 %, respectively (p < 0.001). Patients selected for SR were significantly younger and had better liver functional reserve, performance status, and smaller tumor burden. In the propensity model, the survival benefit of SR remained significant. The estimated 1-, 3-, and 5-year survival rates of patients receiving SR and TACE were 84 versus 71 %, 69 versus 50 %, and 59 versus 35 %, respectively (p = 0.004). The two groups of patients in the propensity score analysis were similar in baseline characteristics. In the Cox proportional hazards model, patients receiving TACE had a 2.044-fold increased risk of mortality compared with patients receiving SR (95 % confidence interval: 1.284–3.252, p = 0.003).Conclusions
For either unselected patients or patients in the propensity model, SR provides significantly better long-term survival than TACE. SR should be considered as a priority treatment in this subgroup of HCC patients. 相似文献55.
Macey L. Murray Yingfen Hsia Karen Glaser Emily Simonoff Declan G. M. Murphy Philip J. Asherson Hanna Eklund Ian C. K. Wong 《Psychopharmacology》2014,231(6):1011-1021
Rationale
Autism spectrum disorders (ASDs) affect 1 % of children, having significant impact on health and social outcomes. Psychotropic medication use by individuals with ASD in the USA increased over time, and polypharmacy occurred in >50 % of those prescribed. In the UK, no psychotropic drugs are approved in ASDs, and little is known about patterns of pharmacological treatment in the ASD population and associated co-morbidities.Methods
We used The Health Improvement Network, a nationally representative primary care database, to assess the prevalence of ASD diagnoses, psychotropic drug prescribing and neuropsychiatric co-morbidities of 0–24 year olds between 1992 and 2008.Results
ASD prevalence increased 65-fold from 0.01 % (1992) to 0.50 % (2008). Psychotropic drugs were prescribed to 29 % (1,619/5,651) of the ASD cohort; the most prescribed drugs were sleep medication (9.7 % of prescribed patients), psychostimulants (7.9 %) and antipsychotics (7.3 %). More patients were given psychostimulants and sleep medications over time from 1.5–6.3 % and 2.2–5.9 % respectively. Thirty-seven per cent of the cohort had ≥1 record of a neuropsychiatric co-morbidity, the most common being developmental difficulties and learning disabilities (12.6 %), behavioural, conduct and personality disorders (11.1 %) and attention deficit hyperactivity disorder (7.5 %).Conclusions
British physicians are more conservative in prescribing practice than American colleagues. However, use of psychostimulants and antipsychotics is much higher in those with ASD than in the general population. Polypharmacy was seen in 34 % of prescribed patients in 2008. Additional studies examining use, efficacy, and long-term safety of antipsychotics and psychostimulants in autistic individuals are warranted. 相似文献56.
57.
Yulia Lin Everad Tilokee Sophie Charg Asim Alam Christine Cserti‐Gazdewich Wendy Lau Christie Lee Lani Lieberman Paula Nixon Wendy Owens Katerina Pavenski Jacob Pendergrast Elianna Saidenberg Nadine Shehata Robert Skeate Qi‐Long Yi David Conrad Jill Dudebout Cyrus C. Hsia Michael Murphy Oksana Prokopchuk‐Gauk Akshay Shah Ziad Solh Jacqueline Trudeau Michelle P. Zeller Jeannie Callum 《Transfusion》2019,59(6):2141-2149
58.
CDR Russell J. Miller Ara A. Chrissian Y. C. Gary Lee Najib M. Rahman Momen M. Wahidi Alain Tremblay David W. Hsia Francisco A. Almeida Samira Shojaee Lakshmi Mudambi Adam R. Belanger Harmeet Bedi Yaron B. Gesthalter Margaret Gaynor Karen L. MacKenney Sandra Zelman Lewis Roberto F. Casal 《Chest》2021,159(3):920-923